Luyan Pharma Co Ltd Capital Reinvestment Ratio
Luyan Pharma Co Ltd capital reinvestment ratio. Luyan Pharma Co Ltd (002788) has a Capital Reinvestment Ratio of 0.64x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥118.98 Million) in capital expenditures (CN¥76.55 Million). See 002788 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Luyan Pharma Co Ltd (2011–2025)
Capital reinvestment ratio of Luyan Pharma Co Ltd from 2011 to 2025. This chart tracks Luyan Pharma Co Ltd's Capital Reinvestment Ratio across 9 annual periods. See 002788 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Luyan Pharma Co Ltd Capital Reinvestment Ratio by Year (2011–2025)
Luyan Pharma Co Ltd capital reinvestment ratio by year from 2011 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Luyan Pharma Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | CN¥688.40 Million | CN¥233.74 Million | ▼ -45.7% |
| 2024 | 0.63x | CN¥577.48 Million | CN¥361.12 Million | ▲ +54.7% |
| 2023 | 0.40x | CN¥1.31 Billion | CN¥529.21 Million | ▼ -71.3% |
| 2022 | 1.41x | CN¥232.19 Million | CN¥327.58 Million | ▼ -36.1% |
| 2020 | 2.21x | CN¥77.22 Million | CN¥170.62 Million | ▲ +109.2% |
| 2018 | 1.06x | CN¥126.77 Million | CN¥133.88 Million | ▼ -99.5% |
| 2015 | 192.80x | CN¥219.31K | CN¥42.28 Million | ▲ +40183.8% |
| 2014 | 0.48x | CN¥177.89 Million | CN¥85.14 Million | ▼ -60.6% |
| 2011 | 1.22x | CN¥28.01 Million | CN¥34.05 Million | — |